Catherine Smith, MD, on whether all acute myeloid leukemia (AML) patients should be tested for FLT3

preview_player
Показать описание
Dr. Smith, Assistant Professor
, Division of Hematology/Oncology, Department of Medicine
, UCSF
, on whether all acute myeloid leukemia (AML) patients should be tested for FLT3
Рекомендации по теме